Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P220003/S032

PASCAL Precision Transcatheter Valve Repair System

Edwards Lifesciences, LLC · Decision date Oct 22, 2026

MEDTECHLEDGER EXPLANATIONP220003/S032

What did the FDA approve?

The FDA database record P220003/S032 lists an approval, dated 2026-10-22, for Edwards Lifesciences, LLC under product code NKM (mitral valve repair devices, cardiovascular specialty). The supplement is categorized as a real-time process submission with the stated reason "Labeling Change - Indications/instructions/shelf life/tradename." The source statement describes the action as approval for extending the device shelf-life to 3-years and revising the shelf-life testing protocol.

The identifier ties the supplement to original PMA P220003 for the PASCAL Precision Transcatheter Valve Repair System; it is a supplement to that PMA, not a new approval of the whole system. The record reports a labeling and protocol change, not clinical outcome data, so it offers no independent proof of safety or effectiveness. Beyond the 3-year target and protocol revision, the record does not disclose the prior shelf-life, the protocol specifics, or which labeling text changed.

FDA approval order statement

Approval for extending the device shelf-life to 3-years and to revise the shelf-life testing protocol
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Oct 22, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P220003/S032
Regulatory pathway
PMA supplement
Product code
NKM
Decision code
APPR
Decision date
Oct 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Mitral valve repair devices.

Product code
NKM
FDA device class
3

For the original device and its historical approval scope, see PMA P220003. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P220003 · Original PMA

    PASCAL Precision Transcatheter Valve Repair System

  2. P220003/S032 received

    Application receipt date recorded by FDA.

  3. P220003/S033 · Related supplement

    PASCAL Precision Transcatheter Valve Repair System

  4. P220003/S028 · Related supplement

    PASCAL Ace with Capture Clarity Valve Repair System MR Implant System

  5. P220003/S029 · Related supplement

    PASCAL Precision Transcatheter Valve Repair System

  6. P220003/S032 · FDA decision

    Real-Time Process

Timeline entries are records held by MedtechLedger for P220003. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P220003

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records